Semax

Semax (Met-Glu-His-Phe-Pro-Gly-Pro)

A synthetic peptide originally developed in Russia and studied, mostly outside the US, for cognitive and neuroprotective research interest.

What Is Semax?

Semax is a synthetic peptide fragment related to ACTH (adrenocorticotropic hormone) that was developed and primarily studied in Russia, where it has a longer history of clinical use for certain neurological conditions under that country's regulatory framework. It has not undergone the same clinical trial process required for FDA approval in the United States. Research interest in Semax centers on its proposed effects on brain-derived neurotrophic factor (BDNF) and related neurochemical pathways, which researchers have studied in the context of focus, memory, and neuroprotection. Much of the published literature on Semax originates from a specific research tradition and has had limited independent replication in Western, peer-reviewed clinical trials.

Why Is Semax Being Studied?

Brain-derived neurotrophic factor (BDNF) signaling
Focus and attention research
Memory and learning pathways
Neuroprotection research models

How Does It Work?

Semax is proposed to influence levels of BDNF and related neurotrophic factors, which are involved in neuron growth, survival, and synaptic plasticity. Researchers have also studied its relationship to the dopaminergic and serotonergic systems in animal models.

Semax

Proposed BDNF & neurotrophic factor signaling

Neuronal plasticity & neurochemical pathways

Cognitive outcomes studied primarily outside the US

What Does The Evidence Say?

Human Research

Human research on Semax has largely been conducted and published within Russia, with limited independent replication in Western peer-reviewed clinical trials. Rigorous, large-scale randomized controlled trial data is not widely available.

Preclinical Research

Animal studies have examined Semax's effects on BDNF expression and behavioral markers related to learning and memory.

What We Don't Know Yet

Whether findings from the existing research base, much of which has limited independent replication, translate reliably to broader populations and long-term use has not been established.

Areas of Research

Cognitive Health

Semax's proposed effect on neurotrophic signaling is the central focus of research interest.

Why Might Someone Discuss This With Their Provider?

Someone interested in cognitive performance research or nootropic peptides may encounter Semax while exploring neurochemical pathway therapies.

Whether a therapy is appropriate depends on individual health history, medications, goals and clinician evaluation.

Important Considerations

Semax is not approved by the FDA for any use in the United States and is not an FDA-approved drug product.

Much of the existing evidence base has limited independent replication outside of its country of origin. Discuss any interest in cognitive-focused peptides with a licensed healthcare provider.

Related Peptides

Selank

A synthetic peptide related to a natural immune regulatory protein, studied mostly outside the US for stress and mood-related research interest.

stressanxietymood

Learn More

Research & References

No references have been added for this entry yet. This library is updated on an ongoing basis.

The Peptide User Guide is provided for educational purposes and is not intended to diagnose, treat, cure, prevent, or provide individualized medical advice. Research surrounding many peptides and investigational therapies continues to evolve, and the strength of evidence varies significantly between compounds and applications. Treatment decisions should be made in consultation with a qualified healthcare professional.